Published in BMJ on June 29, 1996
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation (1987) 7.14
A new coronary prognostic index. Lancet (1969) 6.37
Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med (1987) 4.08
Coronary prognostic index for predicting survival after recovery from acute myocardial infarction. Lancet (1970) 3.58
Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction. Circulation (1975) 2.38
Prognosis after myocardial infarction. Six-year follow-up. Br Heart J (1974) 2.17
Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation (1994) 2.02
Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction. N Engl J Med (1989) 1.91
Trial of propranolol in acute myocardial infarction. Br Med J (1968) 1.89
Mortality in a coronary-care unit analysed by a new coronary prognostic index. Lancet (1969) 1.87
Heart block in posterior and anterior myocardial infarction. Br Heart J (1969) 1.86
Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone. Diabetes Care (1997) 1.76
Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation (1978) 1.68
Plasma propranolol concentration in patients with angina and acute myocardial infarction. Clin Exp Pharmacol Physiol (1976) 1.68
Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking. J Am Coll Cardiol (1990) 1.64
Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction. Br Heart J (1990) 1.54
Clinical trials and clinical practice. Lancet (1993) 1.49
Hospital mortality in acute myocardial infarction. Br Med J (1968) 1.39
Resuscitation equipment and general practitioners. Br J Gen Pract (1997) 1.38
Protective effect of propranolol in threatened myocardial infarction. Lancet (1978) 1.32
Effects of verapamil on infarct size following experimental coronary occlusion. Cardiovasc Res (1975) 1.32
Long term prognosis following treatment in coronary-care unit. Aust N Z J Med (1973) 1.22
Failure of ST segment elevation to predict severity of acute myocardial infarction. Br Heart J (1976) 1.21
Prognosis in unstable angina. Br Heart J (1976) 1.18
Prognosis after recovery from first acute myocardial infarction: determinants of reinfarction and sudden death. Am J Cardiol (1984) 1.18
Conduction disturbances due to anteroseptal myocardial infarction and their treatment by endocardial pacing. Am Heart J (1972) 1.18
Prognosis after myocardial infarction: results of 15 year follow up. Br Med J (Clin Res Ed) (1984) 1.17
Coronary surgery after recurrent myocardial infarction: progress of a trial comparing surgical with nonsurgical management for asymptomatic patients with advanced coronary disease. Circulation (1981) 1.15
Alprenolol in acute myocardial infarction: Double-blind trial. N Z Med J (1970) 1.11
Acute coronary care. N Z Med J (1968) 1.06
Postsystolic shortening of acutely ischemic canine myocardium predicts early and late recovery of function after coronary artery reperfusion. Circulation (1988) 1.06
Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol (1995) 1.05
Bundle branch block in acute myocardial infarction. Am Heart J (1970) 1.02
Anatomy of the nasal profile. J Anat (2008) 0.99
Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction. Br Heart J (1985) 0.99
Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts. Br Heart J (1980) 0.97
Failure of high concentrations of circulating free fatty acids to provoke arrhythmias in experimental myocardial infarction. Lancet (1971) 0.96
Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression. Br Heart J (1995) 0.96
Changes in myocardial blood flow and S-T segment elevation following coronary artery occlusion in dogs. Circ Res (1975) 0.94
Prognosis following acute myocardial infarction. N Z Med J (1973) 0.94
Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet (1984) 0.94
Predictors of late hospital death in acute myocardial infarction. Prog Cardiovasc Dis (1980) 0.93
Idioventricular rhythm complicating acute myocardial infarction. Br Heart J (1970) 0.92
Vitamin A stimulation of parathyroid hormone: interactions with calcium, hydrocortisone, and vitamin E in bovine parathyroid tissues and effects of vitamin A in man. Eur J Clin Invest (1977) 0.91
Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. Am Heart J (1975) 0.91
Comparison of enzymic with cineangiocardiographic estimations of myocardial infarct size. Br Heart J (1980) 0.90
Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. Am J Cardiol (1981) 0.88
Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction. Br Heart J (1977) 0.88
Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs. J Clin Invest (1976) 0.88
Myocardial infarction: is evidence-based medicine the best? Lancet (2002) 0.87
Failure of high doses of propranolol to reduce experimental myocardial ischemic damage. Circulation (1978) 0.87
Post-systolic shortening: a marker of potential for early recovery of acutely ischaemic myocardium in the dog. Cardiovasc Res (1987) 0.86
Amiodarone-induced torsades de pointes. Eur Heart J (1986) 0.84
The effect of verapamil on experimental myocardial ischaemia with a particular reference to regional myocardial blood flow and metabolism. Aust N Z J Med (1977) 0.84
Respiratory gas exchange in patients with spontaneous pneumothorax. Thorax (1968) 0.84
The effect of calcium carbonate dust on ventilation and respiratory gas exchange in normal subjects and in patients with asthma and chronic bronchitis. Clin Sci (1966) 0.83
The effect of glucose-insulin-potassium on experimental myocardial infarction in the dog. Cardiovasc Res (1978) 0.83
Effects of progressive myocardial ischaemia on systolic function, diastolic dysfunction, and load dependent relaxation. Cardiovasc Res (1992) 0.83
Beta adrenoceptor blockade in acute myocardial infarction. Am Heart J (1980) 0.82
"Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction. Am J Cardiol (1995) 0.82
The effects of isoprenaline on epicardial ST-segment elevation, lactate production, and myocardial blood flow following coronary artery ligation. Cardiovasc Res (1975) 0.81
Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk. J Am Coll Cardiol (1991) 0.81
Bradyarrhythmia after myocardial infarction. Lancet (1969) 0.80
Propranolol disposition after acute myocardial infarction. Clin Pharmacol Ther (1984) 0.80
Significance of idioventricular rhythms in acute myocardial infarction. Prog Cardiovasc Dis (1974) 0.79
Sinus rate in acute myocardial infarction. Br Heart J (1972) 0.79
Changes in severity of myocardial infarction and three year survival rates after myocardial infarction in Auckland, 1966-7 and 1981-2. BMJ (1988) 0.78
Severity of canine myocardial infarcts in relation to indices of oxygen demand: preservation of myocardial creatine kinase activity by vagal stimulation and propranolol. Cardiovasc Res (1983) 0.78
Acute myocardial infarction: are there missed opportunities for reperfusion? UK Heart Attack Study Investigators. Coron Artery Dis (1998) 0.78
Beta blockers and infarct size. J Mol Cell Cardiol (1986) 0.78
Redefinition of myocardial infarction. Lancet (2001) 0.77
Can streptokinase produce beneficial effects additional to coronary recanalization? Quantitative microvascular analysis of critically injured reperfused myocardium. Microvasc Res (2000) 0.77
Dissent from the consensus on the redefinition of myocardial infarction. Eur Heart J (2001) 0.76
Vitamin A palmitate decreases intravenous glucose tolerance in man. Acta Vitaminol Enzymol (1982) 0.76
Pressure-length loop area: its components analyzed during graded myocardial ischemia. J Am Coll Cardiol (1991) 0.76
Amiodarone after myocardial infarction: EMIAT and CAMIAT trials. Lancet (1997) 0.75
Intravenous beta-blockers during unstable angina and threatened infarction. Br J Clin Pharmacol (1982) 0.75
Left-ventricular function as an end-point. Lancet (1989) 0.75
Tenecteplase and alteplase in acute myocardial infarction. Lancet (1999) 0.75
Mortality from cardiac arrest. Lancet (1995) 0.75
Variations between countries in invasive cardiac procedures. UK Heart Attack Study investigators. Lancet (1998) 0.75
Progressive left ventricular dysfunction and remodeling after myocardial infarction. Circulation (1994) 0.75
Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction. Br Heart J (1975) 0.75
Clinical applications for decision support systems. Healthc Inf Manage (1992) 0.75
Thrombolytic therapy and recurrent myocardial infarction. N Z Med J (1990) 0.75
Propranolol and vagal nerve stimulation do not affect postsystolic shortening during acute myocardial ischaemia in the dog. Cardiovasc Res (1988) 0.75
Management of acute myocardial infarction in general practice. Drugs (1972) 0.75
Coronary care units. N Z Med J (1971) 0.75
A new coronary prognostic index. Am Heart J (1970) 0.75
Resuscitation from cardiac arrest. N Z Med J (1967) 0.75
Decision support systems and the healthcare strategic planning process: a case study. J Soc Health Syst (1991) 0.75
Delay in admission to a coronary-care unit. N Z Med J (1973) 0.75
Prognosis in acute myocardial infarction. Singapore Med J (1973) 0.75
Digoxin in chronic heart failure. Lancet (1995) 0.75
Factors affecting long-term prognosis after myocardial infarction. Med J Aust (1973) 0.75
Comments on "Analysis of systolic bulging: mechanical characteristics of acutely ischemic myocardium in the conscious dog". Circ Res (1987) 0.75
The clinician's approach to antiarrhythmic therapy. Drugs (1973) 0.75
Bundle-branch block and myocardial infarction. Lancet (1973) 0.75
[Correct communication with blind patients]. Osterr Krankenpflegez (1989) 0.75
Thrombolytic therapy for acute myocardial infarction--round 2. Lancet (1988) 0.75